Risperdal Lawsuits Will Not Include Claims for Punitive Damages

Audet & Partners, LLP reports that a judge in Pennsylvania overseeing hundreds of Risperdal lawsuits has ruled that the plaintiffs in these lawsuits will be barred under New Jersey law from asserting claims for punitive damages.  This ruling, that upheld an earlier ruling in May 2014, in no way affects claims for compensatory damages to cover medical expenses, reconstructive surgery, and the costs of other physical problems caused by Risperdal.

As we have previously reported, Janssen Pharmaceuticals, a division of Johnson & Johnson that manufactured Risperdal, is based in New Jersey.  Under New Jersey law, plaintiffs are expressly precluded from asserting claims for punitive damages associated with pharmaceuticals that were previously approved by the U.S. Food and Drug Administration (FDA).

Audet and Partners, LLP continues to represent many men and boys who suffered from a condition known as Gynecomastia after having been administered Risperdal.  Though punitive damages may be barred under New Jersey law, we will continue to vigorously pursue compensatory damages on behalf of our clients.

If you or a loved one have taken Risperdal, subsequently suffered abnormal growth of great tissue, and been diagnosed with Gynecomastia, you are urged to contact a Risperdal lawyer at Audet & Partners, LLP for a free, confidential case evaluation either by calling (800) 965-1461, or by completing and submitting our online inquiry form on the right side of this page.